Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3105027
Max Phase: Preclinical
Molecular Formula: C31H34O6
Molecular Weight: 502.61
Molecule Type: Small molecule
Associated Items:
ID: ALA3105027
Max Phase: Preclinical
Molecular Formula: C31H34O6
Molecular Weight: 502.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1OC(=O)c1ccc2ccccc2c1)[C@H]1[C@@H](C[C@H]3C)C1(C)C
Standard InChI: InChI=1S/C31H34O6/c1-16-14-30-17(2)11-23-24(29(23,3)4)22(26(30)34)13-21(15-32)25(33)31(30,36)27(16)37-28(35)20-10-9-18-7-5-6-8-19(18)12-20/h5-10,12-14,17,22-25,27,32-33,36H,11,15H2,1-4H3/t17-,22+,23-,24+,25-,27+,30+,31+/m1/s1
Standard InChI Key: IXYHNFDSJUFSHJ-ACECJHEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 502.61 | Molecular Weight (Monoisotopic): 502.2355 | AlogP: 3.83 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.13 | CX Basic pKa: | CX LogP: 3.78 | CX LogD: 3.78 |
Aromatic Rings: 2 | Heavy Atoms: 37 | QED Weighted: 0.44 | Np Likeness Score: 2.48 |
1. Grue-Sørensen G, Liang X, Månsson K, Vedsø P, Dahl Sørensen M, Soor A, Stahlhut M, Bertelsen M, Engell KM, Högberg T.. (2014) Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer., 24 (1): [PMID:24332494] [10.1016/j.bmcl.2013.11.073] |
2. Liu Q, Li W, Huang L, Asada Y, Morris-Natschke SL, Chen CH, Lee KH, Koike K.. (2018) Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui., 156 [PMID:30031972] [10.1016/j.ejmech.2018.07.020] |
Source(1):